NCT05188612 (ISACS-COVID-19) is a clinical trial of Observational (registry) in COVID-19, sponsored by University of Bologna.

Who is sponsoring NCT05188612?

NCT05188612 is sponsored by University of Bologna.

What drugs are being tested in NCT05188612?

Interventions in NCT05188612: Observational (registry).

Is NCT05188612 still recruiting?

NCT05188612 is currently recruiting now. Last updated 27 March 2025.

Last reviewed 2025-03-27 · How we verify

NCT05188612: ISACS-COVID-19

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

International Survey of Acute Coronavirus Syndromes-COVID-19

Recruiting now Last updated 27 March 2025

What this trial tests

trial testing Observational (registry) in COVID-19 in 10,000 participants. Currently enrolling.

Timeline

1 December 2021

Primary endpoint
31 December 2026

31 December 2026

Quick facts

Lead sponsor	University of Bologna
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	10,000
Start date	1 December 2021
Primary completion	31 December 2026
Estimated completion	31 December 2026
Sites	2 locations across Italy, Spain

Drugs / interventions tested

Observational (registry)

Conditions studied

COVID-19 — all drugs for COVID-19 →

Sponsor

University of Bologna

Who can join

18 and older, any sex, with COVID-19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In response to the COVID-19 crisis, ISACS-TC has promoted a new registry of the existing and further centers of the same geographic areas to support clinical research to prevent, and treat the COVID-19 illness. These efforts are made possible by the generous contributions of clinical research volunteers in some of the countries participating to the prior acute coronary syndrome network.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Sex differences and disparities in cardiovascular outcomes of COVID-19.
Bugiardini R, Nava S, Caramori G, Yoon J, et al · · 2023 · cited 7× · PMID 36651866 · DOI 10.1093/cvr/cvad011
Relationship Between Azithromycin and Cardiovascular Outcomes in Unvaccinated Patients With COVID-19 and Preexisting Cardiovascular Disease.
Bergami M, Manfrini O, Nava S, Caramori G, et al · · 2023 · cited 3× · PMID 37449568 · DOI 10.1161/jaha.122.028939
SEX DIFFERENCES AND DISPARITIES IN CARDIOVASCULAR COMPLICATIONS AND INTENSIVE CARE UNIT ADMISSION ASSOCIATED WITH COVID-19
· 2023

Verify or expand the search:

Other trials of Observational (registry)

Trials testing the same drug.

NCT04334291 — International COVID19 Clinical Evaluation Registry, · completed

Other recruiting trials for COVID-19

Currently open trials in the same condition.

NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting

Other University of Bologna trials

Trials by the same sponsor.

NCT07431047 — Fast-Track Protocol for Endovascular Aneurysm Repair (EVAR) of Infrarenal Abdominal Aortic Aneurysms · not yet recruiting
NCT07295197 — Oral Indicators for ED Screening · recruiting
NCT07198789 — Randomized, Double-blind Crossover Trial Comparing Low-GI Functional vs. Standard Wholegrain Carbohydrates on Glycolipid · NA · not yet recruiting
NCT07127796 — Non-inferiority RCT on Fish Waste-Derived vs. Synthetic Vitamin D Supplementation in Healthy Adults With Suboptimal Vita · NA · not yet recruiting
NCT07041060 — Evaluation of the Efficacy and Safety of Eolo in Patients With NERD · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05188612 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Bologna
Last refreshed: 27 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05188612.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing